These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8514654)

  • 1. Audit of prescription and assay of aminoglycosides in a UK teaching hospital.
    Shrimpton SB; Milmoe M; Wilson AP; Felmingham D; Drayan S; Barrass C; Grüneberg RN; Ridgway GL
    J Antimicrob Chemother; 1993 Apr; 31(4):599-606. PubMed ID: 8514654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside prescription, therapeutic monitoring and nephrotoxicity at a university hospital in Saudi Arabia.
    Eltahawy AT; Bahnassy AA
    J Chemother; 1996 Aug; 8(4):278-83. PubMed ID: 8873833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective audit of an aminoglycoside consultative service in a general hospital.
    Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes.
    Li SC; Ioannides-Demos LL; Spicer WJ; Berbatis C; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1989 Aug; 151(4):224-32. PubMed ID: 2761465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital.
    Leong CL; Buising K; Richards M; Robertson M; Street A
    Intern Med J; 2006 Jan; 36(1):37-42. PubMed ID: 16409311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycoside usage and monitoring in a Saudi Arabian teaching hospital: a ten-year laboratory audit.
    Adjepon-Yamoah KK; Al-Homrany M; Bahar Y; Ahmed ME
    J Clin Pharm Ther; 2000 Aug; 25(4):303-7. PubMed ID: 10971782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside toxicity following antibiotic prophylaxis in cardiac surgery.
    Wilson AP; Sturridge MF; Treasure T
    J Antimicrob Chemother; 1990 Nov; 26(5):713-20. PubMed ID: 2079453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve.
    Barclay ML; Duffull SB; Begg EJ; Buttimore RC
    Aust N Z J Med; 1995 Jun; 25(3):230-5. PubMed ID: 7487691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary protocol for determining aminoglycoside dosage.
    Lynch TJ; Possidente CJ; Cioffi WG; Hebert JC
    Am J Hosp Pharm; 1992 Jan; 49(1):109-15. PubMed ID: 1570850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
    Setiabudy R; Suwento R; Rundjan L; Yasin FH; Louisa M; Dwijayanti A; Simanjuntak E
    Int J Clin Pharmacol Ther; 2013 May; 51(5):401-6. PubMed ID: 23557866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iranian surgeons' compliance with the American Society of Health-System Pharmacists guidelines: antibiotic prophylaxis in private versus teaching hospitals in Shiraz, Iran.
    Mahdaviazad H; Masoompour SM; Askarian M
    J Infect Public Health; 2011 Nov; 4(5-6):253-9. PubMed ID: 22118720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective audit of costs and outcome of aminoglycoside treatment and of therapy for gram-negative bacteraemia.
    Davey PG; Parker SE; Orange G; Malek M; Dodd T
    J Antimicrob Chemother; 1995 Sep; 36(3):561-75. PubMed ID: 8830023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of extended-interval aminoglycoside administration in pediatric patients.
    Kraus DM; Pai MP; Rodvold KA
    Paediatr Drugs; 2002; 4(7):469-84. PubMed ID: 12083974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of aminoglycosides usage.
    Ramesh M; John S; Narayanappa D
    Indian J Pediatr; 2002 May; 69(5):385-8. PubMed ID: 12061669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
    Possidente CJ; Lynch T
    Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
    Alghanem S; Paterson I; Touw DJ; Thomson AH
    J Antimicrob Chemother; 2013 Jun; 68(6):1338-47. PubMed ID: 23435691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: a prospective audit in a large UK teaching hospital.
    Warren MM; Gibb AP; Walsh TS
    J Hosp Infect; 2005 Feb; 59(2):90-5. PubMed ID: 15620441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.